SAMYR 400 mg compresse gastroresistenti, Samyr placebo (same excipient as SAMYR)
MYL-1603N-3001
Phase 3 small_molecule active
Quick answer
SAMYR 400 mg compresse gastroresistenti, Samyr placebo (same excipient as SAMYR) for Major Depression Disorder is a Phase 3 program (small_molecule) at Mylan dura GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mylan dura GmbH
- Indication
- Major Depression Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active